<!DOCTYPE html>
<html>
<head>
<title>medicon_curious_learner_questions_brief.md</title>
<meta http-equiv="Content-type" content="text/html;charset=UTF-8">

<style>
/* https://github.com/microsoft/vscode/blob/master/extensions/markdown-language-features/media/markdown.css */
/*---------------------------------------------------------------------------------------------
 *  Copyright (c) Microsoft Corporation. All rights reserved.
 *  Licensed under the MIT License. See License.txt in the project root for license information.
 *--------------------------------------------------------------------------------------------*/

body {
	font-family: var(--vscode-markdown-font-family, -apple-system, BlinkMacSystemFont, "Segoe WPC", "Segoe UI", "Ubuntu", "Droid Sans", sans-serif);
	font-size: var(--vscode-markdown-font-size, 14px);
	padding: 0 26px;
	line-height: var(--vscode-markdown-line-height, 22px);
	word-wrap: break-word;
}

#code-csp-warning {
	position: fixed;
	top: 0;
	right: 0;
	color: white;
	margin: 16px;
	text-align: center;
	font-size: 12px;
	font-family: sans-serif;
	background-color:#444444;
	cursor: pointer;
	padding: 6px;
	box-shadow: 1px 1px 1px rgba(0,0,0,.25);
}

#code-csp-warning:hover {
	text-decoration: none;
	background-color:#007acc;
	box-shadow: 2px 2px 2px rgba(0,0,0,.25);
}

body.scrollBeyondLastLine {
	margin-bottom: calc(100vh - 22px);
}

body.showEditorSelection .code-line {
	position: relative;
}

body.showEditorSelection .code-active-line:before,
body.showEditorSelection .code-line:hover:before {
	content: "";
	display: block;
	position: absolute;
	top: 0;
	left: -12px;
	height: 100%;
}

body.showEditorSelection li.code-active-line:before,
body.showEditorSelection li.code-line:hover:before {
	left: -30px;
}

.vscode-light.showEditorSelection .code-active-line:before {
	border-left: 3px solid rgba(0, 0, 0, 0.15);
}

.vscode-light.showEditorSelection .code-line:hover:before {
	border-left: 3px solid rgba(0, 0, 0, 0.40);
}

.vscode-light.showEditorSelection .code-line .code-line:hover:before {
	border-left: none;
}

.vscode-dark.showEditorSelection .code-active-line:before {
	border-left: 3px solid rgba(255, 255, 255, 0.4);
}

.vscode-dark.showEditorSelection .code-line:hover:before {
	border-left: 3px solid rgba(255, 255, 255, 0.60);
}

.vscode-dark.showEditorSelection .code-line .code-line:hover:before {
	border-left: none;
}

.vscode-high-contrast.showEditorSelection .code-active-line:before {
	border-left: 3px solid rgba(255, 160, 0, 0.7);
}

.vscode-high-contrast.showEditorSelection .code-line:hover:before {
	border-left: 3px solid rgba(255, 160, 0, 1);
}

.vscode-high-contrast.showEditorSelection .code-line .code-line:hover:before {
	border-left: none;
}

img {
	max-width: 100%;
	max-height: 100%;
}

a {
	text-decoration: none;
}

a:hover {
	text-decoration: underline;
}

a:focus,
input:focus,
select:focus,
textarea:focus {
	outline: 1px solid -webkit-focus-ring-color;
	outline-offset: -1px;
}

hr {
	border: 0;
	height: 2px;
	border-bottom: 2px solid;
}

h1 {
	padding-bottom: 0.3em;
	line-height: 1.2;
	border-bottom-width: 1px;
	border-bottom-style: solid;
}

h1, h2, h3 {
	font-weight: normal;
}

table {
	border-collapse: collapse;
}

table > thead > tr > th {
	text-align: left;
	border-bottom: 1px solid;
}

table > thead > tr > th,
table > thead > tr > td,
table > tbody > tr > th,
table > tbody > tr > td {
	padding: 5px 10px;
}

table > tbody > tr + tr > td {
	border-top: 1px solid;
}

blockquote {
	margin: 0 7px 0 5px;
	padding: 0 16px 0 10px;
	border-left-width: 5px;
	border-left-style: solid;
}

code {
	font-family: Menlo, Monaco, Consolas, "Droid Sans Mono", "Courier New", monospace, "Droid Sans Fallback";
	font-size: 1em;
	line-height: 1.357em;
}

body.wordWrap pre {
	white-space: pre-wrap;
}

pre:not(.hljs),
pre.hljs code > div {
	padding: 16px;
	border-radius: 3px;
	overflow: auto;
}

pre code {
	color: var(--vscode-editor-foreground);
	tab-size: 4;
}

/** Theming */

.vscode-light pre {
	background-color: rgba(220, 220, 220, 0.4);
}

.vscode-dark pre {
	background-color: rgba(10, 10, 10, 0.4);
}

.vscode-high-contrast pre {
	background-color: rgb(0, 0, 0);
}

.vscode-high-contrast h1 {
	border-color: rgb(0, 0, 0);
}

.vscode-light table > thead > tr > th {
	border-color: rgba(0, 0, 0, 0.69);
}

.vscode-dark table > thead > tr > th {
	border-color: rgba(255, 255, 255, 0.69);
}

.vscode-light h1,
.vscode-light hr,
.vscode-light table > tbody > tr + tr > td {
	border-color: rgba(0, 0, 0, 0.18);
}

.vscode-dark h1,
.vscode-dark hr,
.vscode-dark table > tbody > tr + tr > td {
	border-color: rgba(255, 255, 255, 0.18);
}

</style>

<style>
/* Tomorrow Theme */
/* http://jmblog.github.com/color-themes-for-google-code-highlightjs */
/* Original theme - https://github.com/chriskempson/tomorrow-theme */

/* Tomorrow Comment */
.hljs-comment,
.hljs-quote {
	color: #8e908c;
}

/* Tomorrow Red */
.hljs-variable,
.hljs-template-variable,
.hljs-tag,
.hljs-name,
.hljs-selector-id,
.hljs-selector-class,
.hljs-regexp,
.hljs-deletion {
	color: #c82829;
}

/* Tomorrow Orange */
.hljs-number,
.hljs-built_in,
.hljs-builtin-name,
.hljs-literal,
.hljs-type,
.hljs-params,
.hljs-meta,
.hljs-link {
	color: #f5871f;
}

/* Tomorrow Yellow */
.hljs-attribute {
	color: #eab700;
}

/* Tomorrow Green */
.hljs-string,
.hljs-symbol,
.hljs-bullet,
.hljs-addition {
	color: #718c00;
}

/* Tomorrow Blue */
.hljs-title,
.hljs-section {
	color: #4271ae;
}

/* Tomorrow Purple */
.hljs-keyword,
.hljs-selector-tag {
	color: #8959a8;
}

.hljs {
	display: block;
	overflow-x: auto;
	color: #4d4d4c;
	padding: 0.5em;
}

.hljs-emphasis {
	font-style: italic;
}

.hljs-strong {
	font-weight: bold;
}
</style>

<style>
/*
 * Markdown PDF CSS
 */

 body {
	font-family: -apple-system, BlinkMacSystemFont, "Segoe WPC", "Segoe UI", "Ubuntu", "Droid Sans", sans-serif, "Meiryo";
	padding: 0 12px;
}

pre {
	background-color: #f8f8f8;
	border: 1px solid #cccccc;
	border-radius: 3px;
	overflow-x: auto;
	white-space: pre-wrap;
	overflow-wrap: break-word;
}

pre:not(.hljs) {
	padding: 23px;
	line-height: 19px;
}

blockquote {
	background: rgba(127, 127, 127, 0.1);
	border-color: rgba(0, 122, 204, 0.5);
}

.emoji {
	height: 1.4em;
}

code {
	font-size: 14px;
	line-height: 19px;
}

/* for inline code */
:not(pre):not(.hljs) > code {
	color: #C9AE75; /* Change the old color so it seems less like an error */
	font-size: inherit;
}

/* Page Break : use <div class="page"/> to insert page break
-------------------------------------------------------- */
.page {
	page-break-after: always;
}

</style>

<script src="https://unpkg.com/mermaid/dist/mermaid.min.js"></script>
</head>
<body>
  <script>
    mermaid.initialize({
      startOnLoad: true,
      theme: document.body.classList.contains('vscode-dark') || document.body.classList.contains('vscode-high-contrast')
          ? 'dark'
          : 'default'
    });
  </script>
<h1 id="medicon-dose-testing---brief-qa">Medicon Dose Testing - Brief Q&amp;A</h1>
<p><em>Essential Case Study Concepts</em></p>
<h2 id="case-context">CASE CONTEXT</h2>
<ol>
<li>
<p><strong>Why test batch quality if vaccine passed clinical trials?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Context)**
<h1 id="context-medicon-is-a-pharmaceutical-company-that-has-manufactured-the-sixth-batch-40000-units-of-a-covid%E2%80%9119-preventive-dose-this-dose-has-already-undergone-clinical-testing-and-around-200000-doses-have-been-administered-across-five-previous-batches-before-roll%E2%80%91out-of-the-six"><strong>Context</strong> Medicon is a pharmaceutical company that has manufactured the <strong>sixth batch (40,000 units)</strong> of a COVIDâ€‘19 preventive dose. This dose has already undergone clinical testing, and <strong>around 200,000 doses</strong> have been administered across <strong>five previous batches</strong>. Before rollâ€‘out of the six</h1>
</div>
- Clinical trials test safety/efficacy. Batch testing ensures manufacturing quality and consistency across production runs.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A[Clinical Trials] --> B["Safety & Efficacy<br/>Approved"]
    B --> C["Manufacturing<br/>Begins"]
    C --> D["Batch Quality<br/>Testing"]
    D --> E["Ensure Consistency"]
</div></code></pre>
<h2 id="binomial-for-dose-quality">BINOMIAL FOR DOSE QUALITY</h2>
<ol start="2">
<li>
<p><strong>Why use Binomial for satisfactory/unsatisfactory doses?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 1 Solution)**
<p>is dose has already undergone clinical testing, and <strong>around 200,000 doses</strong> have been administered across <strong>five previous batches</strong>. Before rollâ€‘out of the sixth batch, Mediconâ€™s <strong>Quality Assurance (QA)</strong> team needs to assess: - The <strong>quality</strong> of the doses in terms of whether each dose does a *sa</p>
</div>
- Two outcomes per dose, fixed n=100 trials, independent doses, constant p=0.09. Perfect Binomial scenario.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A[Dose Quality] --> B["Two Outcomes<br/>Satisfactory/Not"]
    A --> C["Fixed n = 100"]
    A --> D["Independent Doses"]
    A --> E["Constant p = 0.09"]
    B & C & D & E --> F["X ~ Binomial(100, 0.09)"]
</div></code></pre>
<ol start="3">
<li>
<p><strong>How did they calculate p = 0.09?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 1 Solution)**
<p>se will do a satisfactory job or not (yes or no). * The number of trials (n) is fixed - A sample of size 100 is taken. Each dose in the sample represents a trial. * Each trial is independent of the other trials - It is reasonable to assume that giving a dose to each person is independent. * The prob</p>
</div>
- Satisfactory is 10x more likely: p + 10p = 1, so 11p = 1, giving p = 1/11 â‰ˆ 0.09.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">graph TD
    A[Given: Satisfactory 10x More Likely] --> B["Let p = P(Unsatisfactory)"]
    B --> C["P(Satisfactory) = 10p"]
    C --> D["p + 10p = 1"]
    D --> E["11p = 1"]
    E --> F["p = 1/11 = 0.09"]
</div></code></pre>
<ol start="4">
<li>
<p><strong>What does &quot;at most 3 unsatisfactory&quot; mean practically?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 1)**
<p>e** - How long does it typically take for the dose to become effective in the body? - How much variability is there in this time of effect across people? - What can we say about the <strong>true population mean time of effect</strong>, based on a sample? These questions will be addressed using **probability dist</p>
</div>
- P(X â‰¤ 3) = 1.73% means very low probability of few failures. Strong evidence of high batch quality.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A["P(X â‰¤ 3) = 1.73%"] --> B["Very Low Probability"]
    B --> C["Strong Evidence<br/>High Quality"]
    C --> D["QA Decision:<br/>Approve Batch"]
</div></code></pre>
<ol start="5">
<li>
<p><strong>Why calculate &quot;at least 30 failures&quot; for NYC order?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 2)**
<p>unsatisfactory doses ( X ). 2. What is the probability that <strong>exactly 3 doses will not do a satisfactory job</strong>? 3. What is the probability that <strong>at most 3 doses will not do a satisfactory job</strong> out of 100 selected? <br> <strong>Question 2 - Unsatisfactory Doses for a City Order (n = 200)</strong> The **New Yo</p>
</div>
- Quantifies worst-case risk. P(X â‰¥ 30) = 0.3% means extremely low risk. NYC can proceed confidently.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">graph TD
    A[NYC Order: 200 Doses] --> B["P(X â‰¥ 30) = 0.3%"]
    B --> C["Extremely Low Risk"]
    C --> D["Proceed with Order<br/>Confidently"]
</div></code></pre>
<h2 id="normal-for-time-of-effect">NORMAL FOR TIME OF EFFECT</h2>
<ol start="6">
<li>
<p><strong>Why assume Normal distribution for time of effect?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 3)**
<p>ical testing, and <strong>around 200,000 doses</strong> have been administered across <strong>five previous batches</strong>. Before rollâ€‘out of the sixth batch, Mediconâ€™s <strong>Quality Assurance (QA)</strong> team needs to assess: - The <strong>quality</strong> of the doses in terms of whether each dose does a <em>satisfactory job</em> or not. - The **ti</p>
</div>
- With n=50, CLT supports it. Biological processes often normal. Visual check shows approximate normality.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A[Time of Effect Data] --> B["n = 50 Samples"]
    B --> C["CLT Supports<br/>Normality"]
    C --> D["Assume Normal<br/>for Calculations"]
</div></code></pre>
<ol start="7">
<li>
<p><strong>What does 90th percentile (19.52 hours) tell us?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 3)**
<p>ical testing, and <strong>around 200,000 doses</strong> have been administered across <strong>five previous batches</strong>. Before rollâ€‘out of the sixth batch, Mediconâ€™s <strong>Quality Assurance (QA)</strong> team needs to assess: - The <strong>quality</strong> of the doses in terms of whether each dose does a <em>satisfactory job</em> or not. - The **ti</p>
</div>
- 90% of doses effective within 19.52 hours. Helps set patient expectations and plan follow-ups.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A["90th Percentile<br/>19.52 hours"] --> B["90% Effective<br/>Within This Time"]
    B --> C["Set Patient<br/>Expectations"]
    B --> D["Plan Follow-up<br/>Schedules"]
</div></code></pre>
<h2 id="confidence-intervals">CONFIDENCE INTERVALS</h2>
<ol start="8">
<li>
<p><strong>What does 95% CI (12.09, 14.79 hours) mean for QA?</strong></p>
<div style="background-color: #fffef0; border-left: 4px solid #ffd700; padding: 12px; margin: 10px 0; border-radius: 4px;">
**ðŸ“– Reference from Notebook (Question 3)**
<p>ical testing, and <strong>around 200,000 doses</strong> have been administered across <strong>five previous batches</strong>. Before rollâ€‘out of the sixth batch, Mediconâ€™s <strong>Quality Assurance (QA)</strong> team needs to assess: - The <strong>quality</strong> of the doses in terms of whether each dose does a <em>satisfactory job</em> or not. - The **ti</p>
</div>
- True population mean likely between 12.09-14.79 hours. If this range is acceptable, approve batch.
</li>
</ol>
<pre><code class="language-mermaid"><div class="mermaid">flowchart TD
    A["95% CI<br/>12.09 to 14.79 hrs"] --> B{Within Acceptable<br/>Range?}
    B -->|Yes: 10-15 hrs| C["Approve Batch"]
    B -->|No| D["Investigate or<br/>Reject"]
</div></code></pre>
<hr>
<p><em>Total Questions: 8 Core Concepts</em>
<em>Focus: Practical Application of Statistics</em></p>
<p><strong>Key Takeaways:</strong></p>
<ul>
<li>Binomial models discrete quality outcomes</li>
<li>Normal models continuous time measurements</li>
<li>Confidence intervals quantify uncertainty</li>
<li>Statistics guide business decisions</li>
</ul>

</body>
</html>
